Analystreport

Genetic Technologies Limited (NASDAQ: GENE) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating.

Genetic Technologies Ltd - American Depositary Shares  (GENE) 
US:NASDAQ Investor Relations: gtgcorporate.com/investor-centre